BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6854397)

  • 1. Radiographic and scintigraphic skeletal imaging in patients with neuroblastoma: concise communication.
    Baker M; Siddiqui AR; Provisor A; Cohen MD
    J Nucl Med; 1983 Jun; 24(6):467-9. PubMed ID: 6854397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radionuclide bone scanning in neuroblastoma: skeletal metastases and primary tumor localization of 99mTc-MDP.
    Podrasky AE; Stark DD; Hattner RS; Gooding CA; Moss AA
    AJR Am J Roentgenol; 1983 Sep; 141(3):469-72. PubMed ID: 6224402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
    Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
    J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False negative bone scans in neuroblastoma metastatic to the ends of long bones.
    Kaufman RA; Thrall JH; Keyes JW; Brown ML; Zakem JF
    AJR Am J Roentgenol; 1978 Jan; 130(1):131-5. PubMed ID: 202156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radionuclide bone scan in neuroblastoma.
    Heisel MA; Miller JH; Reid BS; Siegel SE
    Pediatrics; 1983 Feb; 71(2):206-9. PubMed ID: 6823421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined radionuclide and radiographic studies of bone metastases in children with neuroblastomas].
    Godin VP; Bukhny AE; Aplevich NN; Kochergina NV; Dzhalalov MD
    Med Radiol (Mosk); 1982 May; 27(5):6-11. PubMed ID: 7098794
    [No Abstract]   [Full Text] [Related]  

  • 7. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
    Sautter-Bihl ML; Bihl H; Heinze HG
    Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between prognosis and scintigraphic evidence of bone metastases in neuroblastoma.
    Daubenton JD; Fisher RM; Karabus CD; Mann MD
    Cancer; 1987 May; 59(9):1586-9. PubMed ID: 3828957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bone-marrow scanning with technetium-99m sulfur colloid in pediatric oncology.
    Siddiqui AR; Oseas RS; Wellman HN; Doerr DR; Baehner RL
    J Nucl Med; 1979 May; 20(5):379-86. PubMed ID: 232146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone scans in neuroblastoma.
    Bhogate BM; Samuel AM; Ramanathan P
    Indian J Cancer; 1993 Mar; 30(1):5-9. PubMed ID: 8500809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear medicine studies in evaluation of skeletal lesions in children with histiocytosis X.
    Siddiqui AR; Tashjian JH; Lazarus K; Wellman HN; Baehner RL
    Radiology; 1981 Sep; 140(3):787-9. PubMed ID: 6456475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide skeletal survey for pediatric neoplasms.
    Gilday DL; Ash JM; Reilly BJ
    Radiology; 1977 May; 123(2):399-406. PubMed ID: 300488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiographic and radionuclide studies of neuroblastoma metastatic to bones].
    Kohda E; Kojima Y; Kubo A; Takagi Y; Katsumata K; Ishida H; Hayashi A; Masaki H; Akiyama H; Koide R
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Jul; 43(7):913-21. PubMed ID: 6634399
    [No Abstract]   [Full Text] [Related]  

  • 14. Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
    Barai S; Bandopadhayaya GP; Malhotra A; Agarwal S; Kumar R; Dhanapathi H
    J Postgrad Med; 2004; 50(4):257-60; discussion 260-1. PubMed ID: 15623965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up in neuroblastoma: comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response.
    Reuland P; Geiger L; Thelen MH; Handgretinger R; Haase B; Müller-Schauenburg W; Niethammer D; Bares R
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):437-42. PubMed ID: 11878578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide skeletal survey in neuroblastoma.
    Howman-Giles RB; Gilday DL; Ash JM
    Radiology; 1979 May; 131(2):497-502. PubMed ID: 441341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroblastoma presenting clinically as hip osteomyelitis: a "signature" diagnosis on skeletal scintigraphy.
    Applegate K; Connolly LP; Treves ST
    Pediatr Radiol; 1995 Nov; 25 Suppl 1():S93-6. PubMed ID: 8577566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal metastases of melanoma: radiographic, scintigraphic, and clinical review.
    Fon GT; Wong WS; Gold RH; Kaiser LR
    AJR Am J Roentgenol; 1981 Jul; 137(1):103-8. PubMed ID: 6787858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallium-67 and technetium-99m-methylene diphosphonate skeletal scintigraphy in determining prognosis for children with stage IV neuroblastoma.
    Macdonald WB; Stevens MM; Dalla Pozza L; Bergin M; Menser MA; Howman-Giles R; Uren RF
    J Nucl Med; 1993 Jul; 34(7):1082-6. PubMed ID: 8315482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-methylene diphosphonate imaging in neural crest tumors.
    Sty JR; Babbitt DP; Casper JT; Boedecker RA
    Clin Nucl Med; 1979 Jan; 4(1):12-7. PubMed ID: 421393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.